Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 298 entries
Sorted by: Best Match Show Resources per page
An electrode cap tested.

Electroencephalography and clinical neurophysiology

Blom JL, Anneveldt M.
PMID: 6181984
Electroencephalogr Clin Neurophysiol. 1982 Nov;54(5):591-4. doi: 10.1016/0013-4694(82)90046-3.

No abstract available.

Cite
Blom JL, Anneveldt M. An electrode cap tested. Electroencephalogr Clin Neurophysiol. 1982;54(5):591-4doi: 10.1016/0013-4694(82)90046-3.
Blom, J. L., & Anneveldt, M. (1982). An electrode cap tested. Electroencephalography and clinical neurophysiology, 54(5), 591-4. https://doi.org/10.1016/0013-4694(82)90046-3
Blom, J L, and Anneveldt, M. "An electrode cap tested." Electroencephalography and clinical neurophysiology vol. 54,5 (1982): 591-4. doi: https://doi.org/10.1016/0013-4694(82)90046-3
Blom JL, Anneveldt M. An electrode cap tested. Electroencephalogr Clin Neurophysiol. 1982 Nov;54(5):591-4. doi: 10.1016/0013-4694(82)90046-3. PMID: 6181984.
Copy Download .nbib Format: NLM
Differential effects of adrenergic antagonists (Carvedilol vs Metoprolol) on parasympathetic and sympathetic activity: a comparison of measures.

Heart international

Vinik AI, Bloom HL, Colombo J.
PMID: 27004091
Heart Int. 2014 Aug 22;9(1):7-14. eCollection 2014.

BACKGROUND: Cardiovascular autonomic neuropathy (CAN) is recognized as a significant health risk. Specific and sensitive measures of CAN are needed for early identification and treatment to avoid complications, preferably in the preclinical state.OBJECTIVES: In this first of two articles,...

Cite
Vinik AI, Bloom HL, Colombo J. Differential effects of adrenergic antagonists (Carvedilol vs Metoprolol) on parasympathetic and sympathetic activity: a comparison of measures. Heart Int. 2014;9(1):7-14
Vinik, A. I., Bloom, H. L., & Colombo, J. (2014). Differential effects of adrenergic antagonists (Carvedilol vs Metoprolol) on parasympathetic and sympathetic activity: a comparison of measures. Heart international, 9(1), 7-14.
Vinik, Aaron I, et al. "Differential effects of adrenergic antagonists (Carvedilol vs Metoprolol) on parasympathetic and sympathetic activity: a comparison of measures." Heart international vol. 9,1 (2014): 7-14.
Vinik AI, Bloom HL, Colombo J. Differential effects of adrenergic antagonists (Carvedilol vs Metoprolol) on parasympathetic and sympathetic activity: a comparison of measures. Heart Int. 2014 Aug 22;9(1):7-14. eCollection 2014. PMID: 27004091; PMCID: PMC4774948.
Copy Download .nbib Format: NLM
Aiming for Study Comparability in Parkinson's Disease: Proposal for a Modular Set of Biomarker Assessments to be Used in Longitudinal Studies.

Frontiers in aging neuroscience

Lerche S, Heinzel S, Alves GW, Barone P, Behnke S, Ben-Shlomo Y, Berendse H, Bloem BR, Burn D, Dodel R, Grosset DG, Hipp G, Hu MT, Kasten M, Krüger R, Liepelt-Scarfone I, Maetzler W, Moccia M, Mollenhauer B, Oertel W, Roeben B, Walter U, Wirdefeldt K, Berg D.
PMID: 27303289
Front Aging Neurosci. 2016 May 27;8:121. doi: 10.3389/fnagi.2016.00121. eCollection 2016.

No abstract available.

Cite
Lerche S, Heinzel S, Alves GW, et al. Aiming for Study Comparability in Parkinson's Disease: Proposal for a Modular Set of Biomarker Assessments to be Used in Longitudinal Studies. Front Aging Neurosci. 2016;8:121doi: 10.3389/fnagi.2016.00121.
Lerche, S., Heinzel, S., Alves, G. W., Barone, P., Behnke, S., Ben-Shlomo, Y., Berendse, H., Bloem, B. R., Burn, D., Dodel, R., Grosset, D. G., Hipp, G., Hu, M. T., Kasten, M., Krüger, R., Liepelt-Scarfone, I., Maetzler, W., Moccia, M., Mollenhauer, B., Oertel, W., Roeben, B., Walter, U., Wirdefeldt, K., & Berg, D. (2016). Aiming for Study Comparability in Parkinson's Disease: Proposal for a Modular Set of Biomarker Assessments to be Used in Longitudinal Studies. Frontiers in aging neuroscience, 8121. https://doi.org/10.3389/fnagi.2016.00121
Lerche, Stefanie, et al. "Aiming for Study Comparability in Parkinson's Disease: Proposal for a Modular Set of Biomarker Assessments to be Used in Longitudinal Studies." Frontiers in aging neuroscience vol. 8 (2016): 121. doi: https://doi.org/10.3389/fnagi.2016.00121
Lerche S, Heinzel S, Alves GW, Barone P, Behnke S, Ben-Shlomo Y, Berendse H, Bloem BR, Burn D, Dodel R, Grosset DG, Hipp G, Hu MT, Kasten M, Krüger R, Liepelt-Scarfone I, Maetzler W, Moccia M, Mollenhauer B, Oertel W, Roeben B, Walter U, Wirdefeldt K, Berg D. Aiming for Study Comparability in Parkinson's Disease: Proposal for a Modular Set of Biomarker Assessments to be Used in Longitudinal Studies. Front Aging Neurosci. 2016 May 27;8:121. doi: 10.3389/fnagi.2016.00121. eCollection 2016. PMID: 27303289; PMCID: PMC4882324.
Copy Download .nbib Format: NLM
Patient involvement in guidelines is poor five years after institute of medicine standards: review of guideline methodologies.

Research involvement and engagement

Armstrong MJ, Bloom JA.
PMID: 29062544
Res Involv Engagem. 2017 Oct 02;3:19. doi: 10.1186/s40900-017-0070-2. eCollection 2017.

BACKGROUND: The United States-based Institute of Medicine 2011 standards for trustworthy clinical practice guideline development recommended patient and public involvement in guideline development via participation by patients and public representatives on guideline development groups and via external review and...

Cite
Armstrong MJ, Bloom JA. Patient involvement in guidelines is poor five years after institute of medicine standards: review of guideline methodologies. Res Involv Engagem. 2017;3:19doi: 10.1186/s40900-017-0070-2.
Armstrong, M. J., & Bloom, J. A. (2017). Patient involvement in guidelines is poor five years after institute of medicine standards: review of guideline methodologies. Research involvement and engagement, 319. https://doi.org/10.1186/s40900-017-0070-2
Armstrong, Melissa J, and Bloom, Joshua A. "Patient involvement in guidelines is poor five years after institute of medicine standards: review of guideline methodologies." Research involvement and engagement vol. 3 (2017): 19. doi: https://doi.org/10.1186/s40900-017-0070-2
Armstrong MJ, Bloom JA. Patient involvement in guidelines is poor five years after institute of medicine standards: review of guideline methodologies. Res Involv Engagem. 2017 Oct 02;3:19. doi: 10.1186/s40900-017-0070-2. eCollection 2017. PMID: 29062544; PMCID: PMC5623959.
Copy Download .nbib Format: NLM
AN ECOLOGICAL ANALYSIS OF PSYCHIATRIC HOSPITALIZATIONS.

Multivariate behavioral research

Bloom BL.
PMID: 26824310
Multivariate Behav Res. 1968 Oct 01;3(4):423-63. doi: 10.1207/s15327906mbr0304_5.

In order to develop some understanding of community social structure and its association with psychiatric inpatient medical care patterns, first admission rates for psychiatric disorders into both public and private facilities were determined for each of the 33 census...

Cite
Bloom BL. AN ECOLOGICAL ANALYSIS OF PSYCHIATRIC HOSPITALIZATIONS. Multivariate Behav Res. 1968;3(4):423-63doi: 10.1207/s15327906mbr0304_5.
Bloom, B. L. (1968). AN ECOLOGICAL ANALYSIS OF PSYCHIATRIC HOSPITALIZATIONS. Multivariate behavioral research, 3(4), 423-63. https://doi.org/10.1207/s15327906mbr0304_5
Bloom, B L. "AN ECOLOGICAL ANALYSIS OF PSYCHIATRIC HOSPITALIZATIONS." Multivariate behavioral research vol. 3,4 (1968): 423-63. doi: https://doi.org/10.1207/s15327906mbr0304_5
Bloom BL. AN ECOLOGICAL ANALYSIS OF PSYCHIATRIC HOSPITALIZATIONS. Multivariate Behav Res. 1968 Oct 01;3(4):423-63. doi: 10.1207/s15327906mbr0304_5. PMID: 26824310.
Copy Download .nbib Format: NLM
CSF Neurofilament Light Chain but not FLT3 Ligand Discriminates Parkinsonian Disorders.

Frontiers in neurology

Herbert MK, Aerts MB, Beenes M, Norgren N, Esselink RA, Bloem BR, Kuiperij HB, Verbeek MM.
PMID: 25999911
Front Neurol. 2015 May 05;6:91. doi: 10.3389/fneur.2015.00091. eCollection 2015.

The differentiation between multiple system atrophy (MSA) and Parkinson's disease (PD) is difficult, particularly in early disease stages. Therefore, we aimed to evaluate the diagnostic value of neurofilament light chain (NFL), fms-like tyrosine kinase ligand (FLT3L), and total tau...

Cite
Herbert MK, Aerts MB, Beenes M, et al. CSF Neurofilament Light Chain but not FLT3 Ligand Discriminates Parkinsonian Disorders. Front Neurol. 2015;6:91doi: 10.3389/fneur.2015.00091.
Herbert, M. K., Aerts, M. B., Beenes, M., Norgren, N., Esselink, R. A., Bloem, B. R., Kuiperij, H. B., & Verbeek, M. M. (2015). CSF Neurofilament Light Chain but not FLT3 Ligand Discriminates Parkinsonian Disorders. Frontiers in neurology, 691. https://doi.org/10.3389/fneur.2015.00091
Herbert, Megan K, et al. "CSF Neurofilament Light Chain but not FLT3 Ligand Discriminates Parkinsonian Disorders." Frontiers in neurology vol. 6 (2015): 91. doi: https://doi.org/10.3389/fneur.2015.00091
Herbert MK, Aerts MB, Beenes M, Norgren N, Esselink RA, Bloem BR, Kuiperij HB, Verbeek MM. CSF Neurofilament Light Chain but not FLT3 Ligand Discriminates Parkinsonian Disorders. Front Neurol. 2015 May 05;6:91. doi: 10.3389/fneur.2015.00091. eCollection 2015. PMID: 25999911; PMCID: PMC4419719.
Copy Download .nbib Format: NLM
Protozoan grazing, bacterial activity, and mineralization in two-stage continuous cultures.

Applied and environmental microbiology

Bloem J, Starink M, Bär-Gilissen MJ, Cappenberg TE.
PMID: 16347801
Appl Environ Microbiol. 1988 Dec;54(12):3113-21. doi: 10.1128/aem.54.12.3113-3121.1988.

In two-stage continuous cultures, at bacterial concentrations, biovolumes, and growth rates similar to values found in Lake Vechten, ingestion rates of heterotrophic nanoflagellates (HNAN) increased from 2.3 bacteria HNAN . h at a growth rate of 0.15 day to...

Cite
Bloem J, Starink M, Bär-Gilissen MJ, et al. Protozoan grazing, bacterial activity, and mineralization in two-stage continuous cultures. Appl Environ Microbiol. 1988;54(12):3113-21doi: 10.1128/aem.54.12.3113-3121.1988.
Bloem, J., Starink, M., Bär-Gilissen, M. J., & Cappenberg, T. E. (1988). Protozoan grazing, bacterial activity, and mineralization in two-stage continuous cultures. Applied and environmental microbiology, 54(12), 3113-21. https://doi.org/10.1128/aem.54.12.3113-3121.1988
Bloem, J, et al. "Protozoan grazing, bacterial activity, and mineralization in two-stage continuous cultures." Applied and environmental microbiology vol. 54,12 (1988): 3113-21. doi: https://doi.org/10.1128/aem.54.12.3113-3121.1988
Bloem J, Starink M, Bär-Gilissen MJ, Cappenberg TE. Protozoan grazing, bacterial activity, and mineralization in two-stage continuous cultures. Appl Environ Microbiol. 1988 Dec;54(12):3113-21. doi: 10.1128/aem.54.12.3113-3121.1988. PMID: 16347801; PMCID: PMC204435.
Copy Download .nbib Format: NLM
Sign inversion of magnetoresistance in space-charge limited organic devices.

Physical review letters

Bloom FL, Kemerink M, Wagemans W, Koopmans B.
PMID: 19792591
Phys Rev Lett. 2009 Aug 07;103(6):066601. doi: 10.1103/PhysRevLett.103.066601. Epub 2009 Aug 06.

In this Letter, we explain the puzzling sign change of organic magnetoresistance in space-charge limited devices by device physics. We prove analytically and numerically that in the case of bipolar conduction with an Ohmic majority carrier and an injection...

Cite
Bloom FL, Kemerink M, Wagemans W, et al. Sign inversion of magnetoresistance in space-charge limited organic devices. Phys Rev Lett. 2009;103(6):066601doi: 10.1103/PhysRevLett.103.066601.
Bloom, F. L., Kemerink, M., Wagemans, W., & Koopmans, B. (2009). Sign inversion of magnetoresistance in space-charge limited organic devices. Physical review letters, 103(6), 066601. https://doi.org/10.1103/PhysRevLett.103.066601
Bloom, F L, et al. "Sign inversion of magnetoresistance in space-charge limited organic devices." Physical review letters vol. 103,6 (2009): 066601. doi: https://doi.org/10.1103/PhysRevLett.103.066601
Bloom FL, Kemerink M, Wagemans W, Koopmans B. Sign inversion of magnetoresistance in space-charge limited organic devices. Phys Rev Lett. 2009 Aug 07;103(6):066601. doi: 10.1103/PhysRevLett.103.066601. Epub 2009 Aug 06. PMID: 19792591.
Copy Download .nbib Format: NLM
Water-formed structures: geomorphology and hydrology of karst terrains.

Science (New York, N.Y.)

Bloom AL.
PMID: 17847267
Science. 1989 Mar 24;243(4898):1618-9. doi: 10.1126/science.243.4898.1618-a.

No abstract available.

Cite
Bloom AL. Water-formed structures: geomorphology and hydrology of karst terrains. Science. 1989;243(4898):1618-9doi: 10.1126/science.243.4898.1618-a.
Bloom, A. L. (1989). Water-formed structures: geomorphology and hydrology of karst terrains. Science (New York, N.Y.), 243(4898), 1618-9. https://doi.org/10.1126/science.243.4898.1618-a
Bloom, A L. "Water-formed structures: geomorphology and hydrology of karst terrains." Science (New York, N.Y.) vol. 243,4898 (1989): 1618-9. doi: https://doi.org/10.1126/science.243.4898.1618-a
Bloom AL. Water-formed structures: geomorphology and hydrology of karst terrains. Science. 1989 Mar 24;243(4898):1618-9. doi: 10.1126/science.243.4898.1618-a. PMID: 17847267.
Copy Download .nbib Format: NLM
Recent advances in the assessment and treatment of falls in Parkinson's disease.

F1000 medicine reports

Snijders AH, Nonnekes J, Bloem BR.
PMID: 21173838
F1000 Med Rep. 2010 Oct 21;2:76. doi: 10.3410/M2-76.

Falls are among the most incapacitating features of Parkinson's disease. Prevention of falls requires a systematic assessment of all contributing factors (with emphasis on freezing of gait and frontal executive dysfunction), and a multidisciplinary treatment approach tailored to the...

Cite
Snijders AH, Nonnekes J, Bloem BR. Recent advances in the assessment and treatment of falls in Parkinson's disease. F1000 Med Rep. 2010;2:76doi: 10.3410/M2-76.
Snijders, A. H., Nonnekes, J., & Bloem, B. R. (2010). Recent advances in the assessment and treatment of falls in Parkinson's disease. F1000 medicine reports, 276. https://doi.org/10.3410/M2-76
Snijders, Anke H, et al. "Recent advances in the assessment and treatment of falls in Parkinson's disease." F1000 medicine reports vol. 2 (2010): 76. doi: https://doi.org/10.3410/M2-76
Snijders AH, Nonnekes J, Bloem BR. Recent advances in the assessment and treatment of falls in Parkinson's disease. F1000 Med Rep. 2010 Oct 21;2:76. doi: 10.3410/M2-76. PMID: 21173838; PMCID: PMC2981191.
Copy Download .nbib Format: NLM
Hydrocephalus induced chorea.

BMJ case reports

Voermans N, Schutte P, Bloem BR.
PMID: 21686773
BMJ Case Rep. 2009;2009. doi: 10.1136/bcr.07.2008.0506. Epub 2009 Jan 23.

Chorea can result from many causes, and the diagnostic workup can be challenging. Although often accompanied by other extrapyramidal symptoms, hydrocephalus has not been mentioned as a possible cause of chorea to date. Here we report an unusual case...

Cite
Voermans N, Schutte P, Bloem BR. Hydrocephalus induced chorea. BMJ Case Rep. 2009;2009doi: 10.1136/bcr.07.2008.0506.
Voermans, N., Schutte, P., & Bloem, B. R. (2009). Hydrocephalus induced chorea. BMJ case reports, 2009. https://doi.org/10.1136/bcr.07.2008.0506
Voermans, Nicol, et al. "Hydrocephalus induced chorea." BMJ case reports vol. 2009 (2009). doi: https://doi.org/10.1136/bcr.07.2008.0506
Voermans N, Schutte P, Bloem BR. Hydrocephalus induced chorea. BMJ Case Rep. 2009;2009. doi: 10.1136/bcr.07.2008.0506. Epub 2009 Jan 23. PMID: 21686773; PMCID: PMC3028014.
Copy Download .nbib Format: NLM
Rapid olefin hydrogenation catalyzed by anion-promoted ruthenium clusters.

Journal of the American Chemical Society

Zuffa JL, Blohm ML, Gladfelter WL.
PMID: 22175503
J Am Chem Soc. 1986 Feb 01;108(3):552-3. doi: 10.1021/ja00263a058.

No abstract available.

Cite
Zuffa JL, Blohm ML, Gladfelter WL. Rapid olefin hydrogenation catalyzed by anion-promoted ruthenium clusters. J Am Chem Soc. 1986;108(3):552-3doi: 10.1021/ja00263a058.
Zuffa, J. L., Blohm, M. L., & Gladfelter, W. L. (1986). Rapid olefin hydrogenation catalyzed by anion-promoted ruthenium clusters. Journal of the American Chemical Society, 108(3), 552-3. https://doi.org/10.1021/ja00263a058
Zuffa, J L, et al. "Rapid olefin hydrogenation catalyzed by anion-promoted ruthenium clusters." Journal of the American Chemical Society vol. 108,3 (1986): 552-3. doi: https://doi.org/10.1021/ja00263a058
Zuffa JL, Blohm ML, Gladfelter WL. Rapid olefin hydrogenation catalyzed by anion-promoted ruthenium clusters. J Am Chem Soc. 1986 Feb 01;108(3):552-3. doi: 10.1021/ja00263a058. PMID: 22175503.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 298 entries